Trade KTTA anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Pasithea Therapeutics Corp. (KTTA) is trading at US$0.58, down 0.07% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$18.02M. Over the past 52 weeks, KTTA has traded between US$0.28 and US$2.06. On Syfe you can trade KTTA with $0 commission and add it to your watchlist.
| Previous close | US$0.58 |
|---|---|
| Market cap | US$18.02M |
| 52-week range | US$0.28 – US$2.06 |
| Volume | 222.51K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp. is a biotechnology company focused on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Lawrence J. Steinman on May 12, 2020 and is headquartered in Miami Beach, FL.
Year: 2021
Pasithea Therapeutics Says Interim Phase 1 Data for PAS-004 Show Durable Clinical Activity
Jun 30, 12:19 PM · MT Newswires
Pasithea Therapeutics Amends PAS-004 Trial to Add Higher Dose Levels, Extend Treatment
Jun 16, 12:34 PM · MT Newswires
Pasithea Therapeutics Corp. (KTTA) stock is trading at US$0.58, -0.07% from the previous close of US$0.58.
The market cap for Pasithea Therapeutics Corp. (KTTA) stock is approximately US$18.02M.
The 52-week high for Pasithea Therapeutics Corp. (KTTA) stock is US$2.06.
The 52-week low for Pasithea Therapeutics Corp. (KTTA) stock is US$0.28.
Pasithea Therapeutics Corp. (KTTA) does not currently pay a dividend.
Stay on top of KTTA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
